Physiological impairment in mild COPD

Respirology

Volumn 21, Issue 2, 2016, Pages 211-223

  O'Donnell, Denis E ^a   Neder, J Alberto ^a   Elbehairy, Amany F ^a,b  

^a KINGSTON GENERAL HOSPITAL   (Canada)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

dyspnoea; exercise; mild chronic obstructive pulmonary disease; small airway remodelling; vascular injury

Indexed keywords

AIRWAY REMODELING; ARTICLE; BLOOD VESSEL INJURY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; EARLY DIAGNOSIS; EXERCISE; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HUMAN; LUNG ALVEOLUS; LUNG GAS EXCHANGE; MICROVASCULATURE; PATHOPHYSIOLOGY; PATIENT CARE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; SPIROMETRY; TREATMENT OUTCOME; ADAPTATION; ADVERSE EFFECTS; LUNG; PATHOLOGY; PATIENT ACUITY; PHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

ADAPTATION, PHYSIOLOGICAL; HUMANS; LUNG; PATIENT ACUITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY GAS EXCHANGE; SMOKING; SPIROMETRY;

EID: 84955340692     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12619     Document Type: Article

References (107)

1. Hogg JC, Macklem PT, Thurlbeck WM,. Site and nature of airway obstruction in chronic obstructive lung disease. N. Engl. J. Med. 1968; 278: 1355-1360.
2. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 2645-2653.
3. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, et al. Small airway obstruction and emphysema in chronic obstructive pulmonary disease. N. Engl. J. Med. 2011; 365: 1567-1575.
4. Matsuoka S, Washko GR, Dransfield MT, Yamashiro T, Estepar RS, Alejandro Diaz A, Silverman EK, Patz S, Hatabu H,. Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad. Radiol. 2010; 17: 93-99.
5. Rodriguez-Roisin R, Drakulovic M, Rodriguez DA, Roca J, Barberà JA, Wagner PD,. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J. Appl. Physiol. 2009; 106: 1902-1908.
6. Wagner PD, Dantzker DR, Dueck R, Clausen JL, West JB,. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J. Clin. Invest. 1977; 59: 203-216.
7. Barbera JA, Riverola A, Roca J, Ramirez J, Wagner PD, Ros D, Wiggs BR, Rodriguez-Roisin R,. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1994; 149: 423-429.
8. Barbera JA, Ramirez J, Roca J, Wagner PD, Sanchez-Lloret J, Rodriguez-Roisin R,. Lung structure and gas exchange in mild chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1990; 141: 895-901.
9. Peinado VI, Barbera JA, Ramirez J, Gomez FP, Roca J, Jover L, Gimferrer JM, Rodriguez-Roisin R,. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am. J. Physiol. 1998; 274: L908-913.
10. Santos S, Peinado VI, Ramirez J, Melgosa T, Roca J, Rodriguez-Roisin R, Barbera JA,. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur. Respir. J. 2002; 19: 632-638.
11. Fletcher C, Peto R,. The natural history of chronic airflow obstruction. Br. Med. J. 1977; 1: 1645-1648.
12. Sutherland EB, Cherniack RM,. Management of chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 2689-2697.
13. Buist AS,. Early detection of airways obstruction by the closing volume technique. Chest 1973; 64: 495-499.
14. Oostveen E, MacLeod D, Lorino H, Farré R, Hantos Z, Desager K, Marchal F, ERS Task Force on Respiratory Impedance Measurements. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur. Respir. J. 2003; 22: 1026-1041.
15. Enright PL,. GOLD stage I is not a COPD risk factor. Thorax 2007; 62: 1107.
16. Mannino DM, Buist AS, Petty TL, Enright P, Redd S,. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58: 388-393.
17. Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R, Rengo F, SaRA Investigators. Do GOLD stages of COPD severity really correspond to differences in health status? Eur. Respir. J. 2003; 22: 444-449.
18. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, Plaza V, Prieto L, Antõ JM,. Chronic obstructive pulmonary disease stage and health-related quality of life: the Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann. Intern. Med. 1997; 127: 1072-1079.
19. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H,. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am. J. Respir. Crit. Care Med. 2008; 177: 743-751.
20. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R,. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 171: 972-977.
21. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2014. [Accessed 15 May 2015.] Available from URL: http://www.goldcopd.org.
22. Shirtcliffe P, Weatherall M, Marsh S, Travers J, Hansell A, McNaughton A, Aldington S, Muellerova H, Beasley R,. COPD prevalence in a random population survey: a matter of definition. Eur. Respir. J. 2007; 30: 232-239.
23. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC,. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill. Summ. 2002; 51: 1-16.
24. Buist AS, McBurnie MA, Vollmer WM, Gilespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al. International variation in the prevalence of COPD (the BOLD study): a population based prevalence study. Lancet 2007; 370: 741-750.
25. Hansen JE, Sun XG, Wasserman K,. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest 2007; 131: 349-355.
26. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann. Intern. Med. 2005; 142: 233-239.
27. Sin DD, Wu L, Man SF,. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
28. Guenette JA, Jensen D, Webb KA, Ofir D, Raghavan N, O'Donnell DE,. Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms. Respir. Physiol. Neurobiol. 2011; 177: 218-227.
29. Bridevaux PO, Probst-Hensch NM, Schindler C, Curjuric I, Felber Dietrich D, Braendli O, Brutsche M, Burdet L, Frey M, Gerbase MW, et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur. Respir. J. 2010; 36: 1259-1269.
30. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, et al. Changes in forced expiratory volume in 1 second overtime in COPD. N. Engl. J. Med. 2011; 365: 1184-1192.
31. Bridevaux PO, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz JM, Rochat T,. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008; 63: 768-774.
32. Thurlbeck W, Angus G,. Growth and aging of the normal human lung. Chest 1975; 67: 3S-6S.
33. Pump KK,. Emphysema and its relation to age. Am. Rev. Respir. Dis. 1976; 114: 5-13.
34. Johnson BD, Reddan WG, Pegelow DF, Seow KC, Dempsey JA,. Flow limitation and regulation of functional residual capacity during exercise in a physically active aging population. Am. Rev. Respir. Dis. 1991; 143: 960-967.
35. Johnson BD, Reddan WG, Seow KC, Dempsey JA,. Mechanical constraints on exercise hyperpnea in a fit aging population. Am. Rev. Respir. Dis. 1991; 143: 968-977.
36. Johnson BD, Dempsey JA,. Demand vs. capacity in the aging pulmonary system. Exerc. Sport Sci. Rev. 1991; 19: 171-210.
37. Holland J, Milic-Emili J, Macklem PT, Bates DV,. Regional distribution of pulmonary ventilation and perfusion in elderly subjects. J. Clin. Invest. 1968; 47: 81-92.
38. Anthonisen NR, Danson J, Robertson PC, Ross WRD,. Airway closure as a function of age. Respir. Physiol. 1969; 8: 58-65.
39. Bode FR, Dosman J, Martin PR, Ghezzo H, Macklem PT,. Age and sex differences in lung elasticity and in closing capacity in non-smokers. J. Appl. Physiol. 1976; 41: 129-135.
40. Guo YF, Herrmann F, Michel JP, Janssens JP,. Normal values for respiratory resistance using forced oscillation in subjects >65 years old. Eur. Respir. J. 2005; 26: 602-608.
41. McClaren SR, Babcock MA, Pegelow DF, Reddan WG, Dempsey JA,. Longitudinal effects of aging on lung function at rest and exercise in healthy active fit elderly adults. J. Appl. Physiol. 1995; 78: 1957-1968.
42. Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, Van de Woestijne KP,. The senile lung. Comparison with normal and emphysematous lungs. 2. Functional aspects. Chest 1992; 101: 800-809.
43. Turner J, Mead J, Wohl M,. Elasticity of human lungs in relation to age. J. Appl. Physiol. 1968; 25: 664-671.
44. Stam H, Hrachovina V, Stijnen T, Versprille A,. Diffusing capacity dependent on lung volume and age in normal subjects. J. Appl. Physiol. 1994; 76: 2356-2363.
45. Kasch FW, Boyer JL, Van Camp SP, Verity LS, Wallace JP,. Effect of exercise on cardiovascular ageing. Age. Ageing 1993; 22: 5-10.
46. Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE,. Sex differences in the perceived intensity of breathlessness during exercise with advancing age. J. Appl. Physiol. 2008; 104: 1583-1593.
47. Faisal A, Webb KA, Guenette JA, Jensen D, Neder JA, O'Donnell DE, Canadian Respiratory Research Network. Effect of age-related ventilatory inefficiency on respiratory sensation during exercise. Respir. Physiol. Neurobiol. 2015; 205: 129-139.
48. Chin RC, Guenette JA, Cheng S, Raghavan N, Amornputtisathaporn N, Cortés-Télles A, Webb KA, O'Donnell DE,. Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? Am. J. Respir. Crit. Care Med. 2013; 187: 1315-1323.
49. Tenney SM, Miller RM,. Dead space ventilation in old age. J. Appl. Physiol. 1956; 9: 321-327.
50. Deesomchok A, Webb KA, Forkert L, Lam YM, Ofir D, Jensen D, O'Donnell DE,. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. COPD 2010; 7: 428-437.
51. Yuan R, Hogg JC, Pare PD, Sin DD, Nakano Y, McWilliam AM, Lam S, Coxson HO,. Prediction of the rate of decline in FEV(1) in smokers using quantitative computed tomography. Thorax 2009; 64: 944-949.
52. Rambod M, Porszasz J, Make BJ, Crapo JD, Casaburi R, COPD Gene Investigators. Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort. Chest 2012; 141: 867-875.
53. Liebow AA,. Pulmonary emphysema with special reference to vascular changes. Am. Rev. Respir. Dis. 1959; 80: 67-93.
54. Wright JL, Lawson L, Pare PD, Hooper RO, Peretz DI, Nelems JM, Schulzer M, Hogg JC,. The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1983; 128: 702-707.
55. Sakao S, Voelkel NF, Tatsumi K,. The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alteration. Eur. Respir. Rev. 2014; 23: 350-355.
56. Hueper K, Vogel-Claussen J, Parikh MA, Austin JH, Bluemke DA, Carr J, Choi J, Goldstein TA, Gomes AS, Hoffman EA, et al. Pulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD Study. Am. J. Respir. Crit. Care Med. 2015. doi: 10.1164/rccm.201411-2120OC.
57. Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey BG, Strulovici-Barel Y, Mezey JG, Crystal RG,. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am. J. Respir. Crit. Care Med. 2011; 184: 224-232.
58. Thomashow MA, Shimbo D, Parikh MA, Hoffman EA, Vogel-Claussen J, Hueper K, Fu J, Liu CY, Bluemke DA, Ventetuolo CE, et al. Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema: the Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease Study. Am. J. Respir. Crit. Care Med. 2013; 188: 60-68.
59. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JAC, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N. Engl. J. Med. 2010; 362: 217-227.
60. Grau M, Barr RG, Lima JA, Hoffman EA, Bluemke DA, Carr JJ,. Percent emphysema and right ventricular structure and function: the MESA lung and MESARV studies. Chest 2013; 144: 136-144.
61. Sabit R, Bolton CE, Fraser AG, Edwards JM, Edwards PH, Jonescu AA, Cockcroft JR, Shale DJ,. Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir. Med. 2010; 104: 1171-1178.
62. Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoffman E, Kalhan R, Lima JA, Liu CY, Michos ED, et al. Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD study. Circulation 2013; 127: 1503-1511.
63. Malerba M, Ragnoli B, Salameh M, Sennino G, Sorlini ML, Radaeli A, Clini E,. Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease. J. Biol. Regul. Homeost. Agents 2011; 25: 443-451.
64. Barbera JA, Peinado VI, Santos S, Ramirez J, Roca J, Rodriquez-Roisin R,. Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am. J. Respir. Crit. Care Med. 2001; 164: 709-713.
65. Voelkel NF, Cool CD,. Pulmonary vascular involvement in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 2003; 46: 28s-32s.
66. Barr RG,. The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema. Proc. Am. Thorac. Soc. 2011; 8: 522-527.
67. Peinado VI, Barbdera JA, Abate P, Ramirez J, Roca J, Santos S, Rodriguez-Roisin R,. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 1605-1611.
68. Vonk-Noordegraaf A, Marcus JT, Holverda S, Roseboom B, Postmus PE,. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest 2005; 127: 1898-1903.
69. Hilde JM, Skjørten I, Grøtta OJ, Hansteen V, Melsom MN, Hisdal J, Humerfelt S, Steine K,. Right ventricular dysfunction and remodelling in chronic obstructive pulmonary disease without pulmonary hypertension. J. Am. Coll. Cardiol. 2013; 62: 1103-1111.
70. Gao Y, Du X, Qin W, Li K,. Assessment of the right ventricular function in patients with chronic obstructive pulmonary disease using MRI. Acta. Radiol. 2011; 52: 711-715.
71. Tjeerdsma G, Szabõ BM, van Wijk LM, Brouwer J, Tio RA, Crijns HJ, van Veldhuisen DJ,. Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade. Eur. J. Heart Fail. 2001; 3: 33-39.
72. Haider T, Casucci G, Linser T, Faulhaber M, Gatterer H, Ott G, Linser A, Ehrenbourg I, Tkatchouk E, Burtscher M, et al. Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease. J. Hypertens. 2009; 27: 1648-1654.
73. Elbehairy AF, Cheng S, Ciavaglia CE, Preston M, Guenette JA, Jensen D, Webb KA, Neder JA, O'Donnell DE,. Predictors of exercise limitation in smokers with preserved spirometry. Am. Thorac. Soc. 2015; A2671.
74. Kirby M, Owrangi A, Svenningsen S, Wheatley A, Coxson HO, Paterson NA, McCormack DG, Parraga G,. On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised heliu-3 MRI. Thorax 2013; 68: 752-759.
75. Barberà JA, Roca J, Ramirez J, Wagner PD, Ussetti P, Rodriguez-Roisin R,. Gas exchange during exercise in mild chronic obstructive pulmonary disease. Correlation with lung structure. Am. Rev. Respir. Dis. 1991; 144: 520-525.
76. Elbehairy AF, Ciavaglia CE, Webb KA, Guenette JA, Jensen D, Mourad SM, Neder JA, O'Donnell DE, on behalf of the Canadian Respiratory Research Network. Pulmonary gas exchange abnormalities in mild COPD: implications for dyspnea and exercise intolerance. Am. J. Respir. Crit. Care Med. 2015; 191: 1384-1394.
77. Neder JA, Arbex FF, Alencar MC, O'Donnell CD, Cory J, Webb KA, O'Donnell DE,. Exercise ventilatory inefficiency in mild to end-stage COPD. Eur. Respir. J. 2015; 45: 377-387.
78. Black LF, Hyatt RE, Stubbs SE,. Mechanism of expiratory airflow limitation in chronic obstructive pulmonary disease associated with 1-antitrypsin deficiency. Am. Rev. Respir. Dis. 1972; 105: 891-899.
79. Leaver DG, Tatterfield AE, Pride NB,. Contributions of loss of lung recoil and of enhanced airways collapsibility to the airflow obstruction of chronic bronchitis and emphysema. J. Clin. Invest. 1973; 52: 2117-2128.
80. Corbin RP, Loveland M, Martin RR, Macklem PT,. A four-year follow-up study of lung mechanics in smokers. Am. Rev. Respir. Dis. 1979; 120: 293-304.
81. Woolcock AJ, Vincent NJ, Macklem PT,. Frequency dependence of compliance as a test for obstruction in the small airways. J. Clin. Invest. 1969; 48: 1097-1106.
82. Dosman J, Bode F, Urbanetti J, Martin R, Macklem PT,. The use of a helium-oxygen mixture during maximum expiratory flow to demonstrate obstruction in small airways in smokers. J. Clin. Invest. 1975; 55: 1090-1099.
83. Crim C, Celli B, Edwards LD, Wouters E, Coxson HO, Tal-Singer R, Calverley PM, ECLIPSE investigators. Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results. Respir. Med. 2011; 105: 1069-1078.
84. Knudson RJ, Burrows B, Lebowitz MD,. The maximal expiratory flow-volume curve: its use in the detection of ventilatory abnormalities in a population study. Am. Rev. Respir. Dis. 1976; 114: 871-879.
85. Rijcken B, Schouten JP, Weiss ST, Meinesz AF, de Vries K, van der Lende R,. The distribution of bronchial responsiveness to histamine in symptomatic and in asymptomatic subjects. A population-based analysis of various indices of responsiveness. Am. Rev. Respir. Dis. 1989; 140: 615-623.
86. Riess A, Wiggs B, Verburgt L, Wright JL, Hogg JC, Paré PD,. Morphologic determinants of airway responsiveness in chronic smokers. Am. J. Respir. Crit. Care Med. 1996; 154: 1444-1449.
87. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, Benzo R, Andre D, Weisman I, Decramer M,. Physical inactivity in patients with COPD, a controlled multicenter pilot-study. Respir. Med. 2010; 104: 1005-1011.
88. Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE,. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008; 177: 622-629.
89. Elbehairy AF, Raghavan N, Cheng S, Yang L, Webb KA, Neder JA, Guenette JA, Mahmoud MI, O'Donnell DE,. Physiologic characterization of the chronic bronchitis phenotype in GOLD grade IB COPD. Chest 2015; 147: 1235-1245.
90. Guenette JA, Chin RC, Cheng S, Dominelli PB, Raghavan N, Webb KA, Neder JA, O'Donnell DE,. Mechanisms of exercise intolerance in global initiative for chronic obstructive lung disease grade 1 COPD. Eur. Respir. J. 2014; 44: 1177-1187.
91. Whipp BJ, Ward SA, Wasserman K,. Ventilatory responses to exercise and their control. Am. Rev. Respir. Dis. 1984; 129: S17-20.
92. Voelkel NF, Gomez-Arroyo J, Mizuno S,. COPD/emphysema: the vascular story. Pulm. Circ. 2011; 1: 320-326.
93. Whipp BJ,. The bioenergetic and gas exchange basis of exercise testing. Clin. Chest Med. 1994; 15: 173-192.
94. O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D,. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax 2009; 64: 216-223.
95. Casaburi R, Maltais F, Porszasz J, Albers F, Deng O, Iqbal A, Paden HA, O'Donnell DE, on behalf of the 205.440 Investigators. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease. Ann. Am. Thorac. Soc. 2014; 11: 1351-1361.
96. Jacome C, Marques A,. Impact of pulmonary rehabilitation in subjects with mild COPD. Respir. Care 2014; 59: 1577-1582.
97. Jacome C, Marques A,. Pulmonary rehabilitation for mild COPD: a systematic review. Respir. Care 2014; 59: 588-594.
98. Marwick JA, Stevenson CS, Giddings J, MacNee W, Butler K, Rahman I, Kirkham PA,. Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006; 290: L897-908.
99. De Boer WI, Alagappan VK, Sharma HS,. Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy. Cell Biochem. Biophys. 2007; 47: 131-148.
100. 1 decline and chronic obstructive pulmonary disease morbidity. Am. J. Respir. Crit. Care Med. 1996; 153: 1530-1535.
101. Burgel PR, Nesme-Meyer P, Chanez P, Caillaud D, Carre P, Perez T, Roche N, on behalf of the Initiatives Bronchopneumopathie Chronique Obstructive (BPCO) Scientific Committee. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009; 135: 975-982.
102. Prescott E, Lange P, Vestbo J,. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur. Respir. J. 1995; 8: 1333-1338.
103. Miravitlles M, Guerrero T, Mayordomo C, Sánchez-Agudo L, Nicolau F, Segú JL, The EOLO Study Group. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration 2000; 67: 495-501.
104. Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, Hersh CP, Stinson D, Silverman EK, Criner GJ, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPD Gene Study. Chest 2011; 140: 626-633.
105. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Löfdahl CG,. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir. Res. 2005; 6: 98-106.
106. O'Donnell DE, Gebke KB,. Activity restriction in mild COPD: a challenging clinical problem. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 577-588.
107. Pelkonen M, Tukiainen H, Tervahauta M, Notkola IL, Kivelä SL, Salorinne Y, Nissinen A,. Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax 2000; 55: 746-750.